Matrix metalloproteinases, inhibitor of metalloproteinases mRNA and protein expression in laryngeal squamous cell carcinoma

Matrix metalloproteinases, inhibitor of metalloproteinases mRNA and protein expression in laryngeal squamous cell carcinoma

Bibliographic Details
Main Authors:	Weronika Lucas Grzelczyk, Artur Wróbel-Roztropiński, Janusz Szemraj, Magdalena Cybula, Wioletta Pietruszewska, Bogna Zielińska-Kaźmierska, Magdalena Józefowicz-Korczyńska
Format:	Article
Language:	English
Published:	Termedia Publishing House 2019-04-01
Series:	Archives of Medical Science
Subjects:	matrix metalloproteinase laryngeal cancer tissue inhibitor of metalloproteinase
Online Access:	https://www.termedia.pl/Matrix-metalloproteinases-inhibitor-of-metalloproteinases-mRNA-and-protein-expression-in-laryngeal-squamous-cell-carcinoma,19,31363,1,1.html

Similar Items

Clinical significance of matrix metalloproteinase (MMP)-2 and MMP-9 expression in laryngeal squamous cell carcinoma
by: Rašić Dejan, et al.
Published: (2021-01-01)

Serum expression of selected miRNAs in patients with laryngeal squamous cell carcinoma (LSCC)
by: Weronika Lucas Grzelczyk, et al.
Published: (2019-05-01)

Immunohistochemical Study of Metalloproteinases (MMP-2 and MMP-9) Expression in Laryngeal Squamous Cell Carcinoma
by: Zeinab Yehia Abdel-Meguid, et al.
Published: (2019-07-01)

Metalloproteinase and tissue inhibitor of metalloproteinase in tuberculosis and malignant pleural effusion
by: Nesriene Mohamad El Margoushy, et al.
Published: (2013-04-01)

Expression of matrix metalloproteinase-2 and 9 with their inhibitors, tissue inhibitors of metalloproteinase-1 and 2 in oral lichen planus
by: Natheer Hashim Al-Rawi, et al.
Published: (2014-01-01)

METALLOPROTEINASE AND ATHEROSCLEROSIS
by: Ya. V. Polonskaya, et al.
Published: (2017-09-01)

Matrix Metalloproteinases/Tissue Inhibitors of Metalloproteinases Ratio: A Biomarker of Bone Resorption in Geriatric Osteoporosis?
by: Bahar Bektan Kanat, et al.
Published: (2023-06-01)

The Roles of Matrix Metalloproteinases and Their Inhibitors in Human Diseases
by: Griselda A Cabral-Pacheco, et al.
Published: (2020-12-01)

Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases in Echinoderms: Structure and Possible Functions
by: Igor Yu. Dolmatov, et al.
Published: (2021-09-01)

Treatment with bestatin (the exogenous synthetic inhibitor of metalloproteinases) reduces the activity of metalloproteinase 2 and 12 in the spleen and lung tissues of rats in a model of lipopolysaccharide-induced sepsis
by: Barbara Nieradko-Iwanicka, et al.
Published: (2024-05-01)

Evaluation of the Expression of Matrix Metalloproteinase-1 of Laryngeal Squamous Cell Carcinoma by Ultrasound Molecular Imaging
by: Yi Zhou, et al.
Published: (2019-06-01)

Time-dependent matrix metalloproteinases and tissue inhibitor of metalloproteinases expression change in fusarium solani keratitis
by: Qian Li, et al.
Published: (2016-04-01)

The Role of Matrix Metalloproteinases in Colorectal Cancer
by: Anan H. Said, et al.
Published: (2014-02-01)

Matrix metalloproteinases and their tissue inhibitors as novel markers in invasive pituitary adenomas – a review
by: Joanna Szydełko, et al.
Published: (2019-09-01)

Matrix metalloproteinases and their tissue inhibitors as novel markers in invasive pituitary adenomas – a review
by: Joanna Szydełko, et al.
Published: (2019-09-01)

Characteristics of Expression of Matrix Metalloproteinases (MMP-2 and MMP-9) in Glottic Squamous Cell Carcinoma and Benign Vocal Fold Lesions
by: Virgilijus Uloza, et al.
Published: (2015-03-01)

Polymerizable Matrix Metalloproteinases’ Inhibitors with Potential Application for Dental Restorations
by: Helena Laronha, et al.
Published: (2021-03-01)

Matrix metalloproteinases-9 and tissue inhibitor of matrix metalloproteinases-1 in sarcoidosis patients
by: Ivanišević Jasmina, et al.
Published: (2017-01-01)

The content of matrix metalloproteinase-1, -9 and tissue inhibitor of matrix metalloproteinase-1 in patients with bronchial asthma and obesity
by: V. V. Kachkovska, et al.
Published: (2023-12-01)

Eotaxin-induced expression of membrane type 1 matrix metalloproteinase mRNA in human eosinophils
by: Izumi Kurosaki, et al.
Published: (2000-01-01)

Effect of nanoparticles on the expression and activity of matrix metalloproteinases
by: Matysiak-Kucharek Magdalena, et al.
Published: (2018-12-01)

Changes in Serum Levels of Matrix Metalloproteinase-1 and Tissue Inhibitor of Metalloproteinases-1 in Patients with Essential Hypertension
by: Krasimir Kostov, et al.
Published: (2022-03-01)

Expression of Matrix Metalloproteinase-2/9 and Tissue Inhibitor of Metalloproteinase-1/2 as Predictive Factors in Oropharyngeal Squamous Cell Carcinoma
by: Pawel Burduk, et al.
Published: (2019-05-01)

The impact of changes in serum levels of metalloproteinase-2 and metalloproteinase-9 on pain perception in patients with disc herniation before and after surgery
by: Kamieniak P, et al.
Published: (2019-05-01)

Sub-Cellular Localization of Metalloproteinases in Megakaryocytes
by: Alessandro Malara, et al.
Published: (2018-07-01)

Metalloproteinases as biochemical markers of pregnancy pathology
by: K. N. Grigorieva, et al.
Published: (2022-03-01)

Evaluation of matrix metalloproteinase-9 and tissue inhibitor metalloproteinase-1 levels in bronchoalveolar lavage of apparently healthy smokers
by: Ali M. Abdella, et al.
Published: (2015-04-01)

Matrix metalloproteinase 2 and tissue inhibitor of matrix metalloproteinases 2 in the diagnosis of colorectal adenoma and cancer patients
by: Magdalena Groblewska, et al.
Published: (2010-04-01)

Quercetin prevent proteoglycan destruction by inhibits matrix metalloproteinase-9, matrix metalloproteinase-13, a disintegrin and metalloproteinase with thrombospondin motifs-5 expressions on osteoarthritis model rats
by: Dian Agustina Permatasari, et al.
Published: (2019-01-01)

Association of matrix metalloproteinase-1, 9, 12 and tissue inhibitor of metalloproteinase-1 gene polymorphisms in malay male essential hypertensive subject
by: Tabatabaee, Farizeh Aalam Ghomi
Published: (2015)

The role of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in the development of esophageal cancer
by: Maciej Szmitkowski, et al.
Published: (2012-04-01)

Metalloproteinases and Their Inhibitors: Potential for the Development of New Therapeutics
by: Maryam Raeeszadeh-Sarmazdeh, et al.
Published: (2020-05-01)

Perioceutics: Matrix metalloproteinase inhibitors as an adjunctive therapy for inflammatory periodontal disease
by: Esther Nalini Honibald, et al.
Published: (2012-01-01)

Matrix Metalloproteinases in Health and Disease
by: Raffaele Serra
Published: (2020-08-01)

MATRIX METALLOPROTEINASES AND TISSUE INHIBITORS OF MATRIX METALLOPROTEINASES DURING PREGNANCY AND DELIVERY
by: Yu. V. Korenovsky, et al.
Published: (2012-09-01)

Snake Venom Metalloproteinases (SVMPs): A structure-function update
by: Olamide Tosin Olaoba, et al.
Published: (2020-09-01)

Evaluation of the Effects of Increased Parathyroid Hormone (PTH) Following Myocardial Infarction on the Expressions Level of Matrix Metalloproteinase 9 and Tissue Inhibitor Metalloproteinase
by: Faezeh Hoseini, et al.
Published: (2017-11-01)

Expression of tissue levels of matrix metalloproteinases and tissue inhibitors of metalloproteinases in renal cell carcinoma
by: Qiao Zhen-kui, et al.
Published: (2013-01-01)

Significance of matrix metalloproteinases and their ihhibitors in normal subjects, solid and blood cancer patients
by: Nadezhda Vladimirovna Gaydamaka, et al.
Published: (2009-07-01)

The role of matrix metalloproteinases in early and late gonarthrosis manifestations
by: Ekaterina V. Gladkova
Published: (2020-09-01)